Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer
Status:
Active, not recruiting
Trial end date:
2024-12-11
Target enrollment:
Participant gender:
Summary
We star a multicentre, one-armed, clinical pilot trial intends to investigate the safety and
effectiveness of Apatinib Combined With Oxaliplatin, Gimeracil and Oteracil Porassium
Capsules Neoadjuvant Ttherapy for Locally Advanced Gastric Cancer(cT2-4/N+M0)